These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prophylactic attempts in Rh-sensitized pregnant women with progesterone, vitamin K and antihistaminics]. HOLLANDER R Zentralbl Gynakol; 1955; 77(16):609-15. PubMed ID: 14397719 [No Abstract] [Full Text] [Related]
4. [5-year experience with work of the consultation clinic for pregnant mothers sensitized in the Rh system]. Mĕrka J; Petyko I; Gindl E Cesk Gynekol; 1969 Oct; 34(8):500-1. PubMed ID: 4982158 [No Abstract] [Full Text] [Related]
5. Cortisone and erythroblastosis; evaluation of management of pregnancy in the Rh-immunized woman. DECOSTA EJ; GERBIE AB; POTTER EL Obstet Gynecol; 1954 Feb; 3(2):131-40. PubMed ID: 13133230 [No Abstract] [Full Text] [Related]
6. Report on treatment of obstetric Rh isoimmunization with hapten. EHRENBERG CJ J Lancet; 1955 Jun; 75(6):275-7. PubMed ID: 14381742 [No Abstract] [Full Text] [Related]
7. [Management of Rh-negative pregnant women]. LACOMBE V An Bras Ginecol; 1959 May; 47(5):257-64. PubMed ID: 13661605 [No Abstract] [Full Text] [Related]
8. [Systematic determination of iso-immunization to Rh antigens; French study based on 6,000 examinations]. CHRISTIAENS L; GOUDEMAND M; SAMAILLE J Acta Chir Belg; 1954 Mar; 53(Suppl. 1):59-66. PubMed ID: 13188531 [No Abstract] [Full Text] [Related]
9. [Premature therapeutic interruption of pregnancy in cases of anti-Rh iso-immunization]. PIGEAUD H; GABRIEL H Gynecol Obstet (Paris); 1955; 54(2):202-8. PubMed ID: 14391767 [No Abstract] [Full Text] [Related]
10. [Erythroblastosis in an Rh negative newborn infant of an Rh negative mother with anti-D antibodies]. GUASCH J Acta Chir Belg; 1954 Mar; 53(Suppl. 1):118-25. PubMed ID: 13188538 [No Abstract] [Full Text] [Related]
11. Noninvasive fetal Rh genotyping: the time has come. Queenan JT Obstet Gynecol; 2005 Oct; 106(4):682-3. PubMed ID: 16199621 [No Abstract] [Full Text] [Related]
12. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease. Aylin T; Berkan G Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869 [No Abstract] [Full Text] [Related]
17. The safety of RhIG in the prevention of haemolytic disease of the newborn. Hirose TG; Mays DA J Obstet Gynaecol; 2007 Aug; 27(6):545-57. PubMed ID: 17896248 [No Abstract] [Full Text] [Related]
18. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis. Kumpel BM Transfusion; 2006 Aug; 46(8):1271-5. PubMed ID: 16934058 [No Abstract] [Full Text] [Related]
19. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Daniels G; Finning K; Martin P; Soothill P Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017 [TBL] [Abstract][Full Text] [Related]
20. [Fetal erythroblastosis & prophylactic Rh group examination in pregnant women; review & commentary on the new prophylactic Rh group study in connection with pregnancy tests]. FREIESLEBEN E; FRIEDENREICH V Ugeskr Laeger; 1958 Mar; 120(13):405-11. PubMed ID: 13557081 [No Abstract] [Full Text] [Related] [Next] [New Search]